JOHNSON FRANKLIN P JR 4
4 · AMGEN INC · Filed Jan 12, 2005
Insider Transaction Report
Form 4
AMGEN INCAMGN
JOHNSON FRANKLIN P JR
Director
Transactions
- Exercise/Conversion
Common Stock
2005-01-10$7.67/sh+18,400$141,163→ 898,622 total - Exercise/Conversion
NQSO (Right to Buy)
2005-01-10−18,400→ 0 totalExercise: $7.67From: 1995-01-27Exp: 2005-01-27→ Common Stock (18,400 underlying)
Footnotes (1)
- [F1](FPJ 01.10.05) Does not include (i) 634,400 shares held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner, (ii) 4 units contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934.